ARTICLE | Company News
Ricerca, Eli Lilly deal
December 9, 2002 8:00 AM UTC
Ricerca received an exclusive license to certain LLY antibacterial targets and IP. Ricerca may develop and commercialize small molecules against the targets. LLY will receive an upfront payment and an...